Table 2.
First Author | Intervention | Payer type | Study Design | Setting | Cancer studied | Peer-review | Patients in intervention | control | Brief Description | Outcomes Measured | Results | Impact on Value |
---|---|---|---|---|---|---|---|---|
Bundled Payments | ||||||||
Bandell14 | BCBS of Florida Radical Prostatectomy Bundle | Private | NA | Community | Prostate | No | NA | BCBS partnered with Mobile Surgery International to develop prostatectomy bundle for early stage prostate cancer. | NA | NA | NA |
Butcher15 | CTCA Bundle | Private | NA | Community | prostate, breast, lung and colorectal | No | NA | CTCA developed a bundle for the diagnosis and care planning of 4 cancer types. Episodes included medical, surgical and radiation oncologist consults, imaging and pathology services, and other consult services. | NA | NA | NA |
Castelluci16 | BCBS of CA Breast Cancer Bundle | Private | NA | Community | Breast | No | NA | BCBS partnered with Valley Radiotherapy Associated Medical Group to develop a radiation bundle for early stage breast cancer. | NA | NA | NA |
Feeley17 | MD Anderson Head and Neck Bundle | Private | NA | NCI designated cancer center | Head and neck | No | NA | UHC partnered with MD Anderson to develop a bundle covering comprehensive services to manage head and neck cancer. Episode length of 12 months. | NA | NA | NA |
Loy18 | EBRT Bundle | Private | Pre-post with concurrent control | Community | Breast, Lung, Skin, Prostate cancer, and Bone metastases | Yes | 515 | 433 | Humana partnered with 21st Century Oncology practice to form a bundle for EBRT. Episode length of 90 days. | Guideline concordance, under- and over- treatment. | No change in guideline concordant care for breast, lung, and skin cancers. Improvements in guideline care for bone metastases and prostate cancer. Under-treatment declined from 4% to 0%. Over-treatment was unchanged. |
Neutral |
Newcomer19 | UHC Bundle Pilot | Private | Pre-post with concurrent control | Community | Breast, lung, colon | Yes | 810 | NA | UHC partnered with 5 medical oncology groups. Episodes included hospital care, hospice, case management, and eliminated % based chemotherapy drug incentive. Episodes length of 4–12 months. | Hospitalizations, therapeutic radiology use, chemotherapy drug cost, net savings. | Decreased hospitalization and therapeutic radiology use. Increase in chemotherapy drug costs. Net savings of $33.36 million. |
Increased |
Accountable Care Organizations | ||||||||
Butcher20 | Aetna Cancer-Specific ACO | Private | Pre-post for costs, Cohort study for utilization | Community | Breast, Lung, Colon | No | 184 | NA | Aetna partnered with Texas Oncology to form ACO pilot. | ER visits, hospitalizations, LOS, costs. | 40% fewer emergency room visits. 16.5% fewer hospitalizations. 36% fewer inpatient days. 10% lower 1-year costs, 12% lower 2-year costs. | Increased |
Colla21 | PGPD Project | Medicare | Pre-post with concurrent control | Community | All | Yes | 104,766 | 727,969 | Medicare claims analysis of cancer outcomes after PGPD. | Hospitalizations, costs. | PGPD enrollment was associated with a $721 (3.9%) reduction in annual Medicare spend per patient, which was driven exclusively by decreased inpatient stays. | Increased |
Herrel22 | MSSP ACO Analysis | Medicare | Pre-post with concurrent control | Mixed settings | Colorectal, bladder, esophageal, kidney, liver, ovarian, pancreatic, lung, or prostate cancer | Yes | 19,439 | 365,080 | Medicare claims analysis of surgical cancer outcomes after MSSP enrollment. | Mortality, readmissions, complications, LOS. | ACO enrollment had no effect on 30-day mortality, readmissions, complications, or LOS. | Neutral |
Mehr23 | BCBS Cancer- Specific ACOs | Private | NA | NCI designated cancer center, Community | All | Yes | NA | BCBS partnered with Moffit Cancer Center, Baptist Health South Florida and Advanced Medical Specialties, to form a cancer ACO. | NA | NA | NA |
Patient Centered Medical Homes | ||||||||
Bosserman24 | Wilshire Oncology Pilot| Private | NA | Community | All | Yes | NA | Wilshire Oncology partnered with CA Anthem Blue Cross WellPoint to form an oncology medical home pilot. | NA | NA | NA |
Butcher25 | COA Initiative | Mixed | NA | Community | All | No | NA | COA approached CMMI and private payers about a medical home demonstration project. | NA | NA | NA |
Goyal27 | North Carolina Medicaid PCMH | Medicaid | Concurrent comparator | Mixed settings | Breast | Yes | 308 | 262 | Medicaid claims analyses of breast cancer patients enrolled in the Community Care of North Carolina PCMH. | Outpatient or ER visits for chemo-related adverse event. | PMCH enrollment was not associated with differences in outpatient or ER visits for chemo-related adverse events. | Decreased |
Kohler26 | Concurrent comparator | Mixed settings | Breast | Yes | 3,857 person-months | 5,550 person-months | Medicaid claims analyses of breast cancer patients enrolled in the Community Care of North Carolina PCMH. | Outpatient service use, ER visits, hospitalizations, costs. | PCMH enrollment was associated with higher monthly outpatient service utilization, no effect on ER visits or hospitalizations, and a $429 per month increase in expenditures for the first 15 months. This effect was not significant at 24–36 months. | ||
Kuntz28 | Michigan Oncology Medical Home | Private | Pre-Post | Community | All | Yes | 85 | 485 | 4 oncology practices partnered with Priority Health to develop a model that reimbursed for chemo and treatment planning and advanced care planning consultation with a shared savings opportunity. | ER visits, hospitalizations, costs. | Reduced ER visits by 47% and hospitalizations by 68%. Estimated savings per patient was $550. | Increased |
Reinke29 | CareFirst | Private | Pre-post with concurrent control | NA | NA | No | 8 pilot practices | 7 control practices | A Maryland/Washington BCBS plan that created a voluntary medical home model based on its pathway program. | Office visits, # cycles per patient, % receiving chemo, % receiving all-generic chemotherapy. | No effect on office visits, average number of cycles given per patient, proportion of patients receiving chemotherapy, and proportion of patients receiving all-generic chemotherapy. | Neutral |
Shah30 | National PCMH | NA | Concurrent comparator | Mixed settings | All | No* | NA | NA | Survey analysis of PCMH access and outcomes for cancer survivors. | ER visits, prescribing behavior, outpatient visits, hospitalizations, costs. | Reduced ER visits and prescription medications for cancer survivors with access to PCMH. No effect on outpatient visits, hospitalizations, or total costs. | Neutral |
Sprandio12 | CMOH | Private | Pre-post | Community | All | Yes | NA|NA | CMOH, a nine-Oncologist physician practice, formed the first oncology medical home. | ER visits, hospitalizations, LOS, costs. | Reduced ER visits by 68%, hospitalizations by 51%, and LOS by 21%. Approximate aggregate savings of $1 million per physician per year to insurers. | Increased |
Tirodkar31 | Patient-centered oncology practice standards pilot | NA | NA | Mixed | NA | Yes | NA | Pilot of incorporating patient-centered oncology practice standards at 5 oncology practices. Standards included improved communication, care coordination, and performance measurement. | NA | NA | NA |
Waters32 | COME HOME | Medicare | Pre-Post | Community | Breast, Lung, or Colon | Yes | 16,353 | NA | Received a grant from CMMI to replicate and scale a patient centered cost-reduction program across 7 oncology practices. | ER visits, hospitalizations, patient satisfaction. | Participating sites reduced ER visits by 23% and hospitalizations by 28%. Patient satisfaction rates remained >90%. | Increased |
Other Alternative Payment or Care Delivery Interventions | ||||||||
Kwon33 | Glioma IPU | NA | NA | Community | Glioma, metastatic cancer to the brain, meningioma | No* | NA | Virtual IPU including neurosurgery, neuro oncology, radiation oncology, neuroradiology, and neuropathology. | NA | NA | NA |
Sharma34 | The Diabetes Oncology Program | NA | Pre-post | Community | All | No× | 98 | 383 | Integrated care model including oncologist, endocrinologist, primary care physician, nursing staff, and diabetes educator. | ER visits, hospitalizations. | Reduced aggregate ER visits, observation stays, and hospitalizations by 3.4% in cancer patients with diabetes. | Increased |
Timmins35 | Gynecologic Oncology capitated model | Private | NA | Community | Gynecologic cancers | No* | NA | Private practice group partnered with health plan to create a capitated annual payment per patient (excluding drug costs). | NA | NA | NA |
Abbreviations: BCBS = Blue Cross Blue Shield; NA = Not available; CTCA = Cancer Treatment Centers of America; CA = California; NCI = National Cancer Institute; UHC = United Healthcare; EBRT = External beam radiation; ER = Emergency room; LOS = length of stay; PGPD = Physician Group Practice Demonstration; MSSP = Medicare Shared Savings Program; COA = Community Oncology Alliance; CMMI = Center for Medicare & Medicaid Innovation; CMOH = Consultants in Medical Oncology and Hematology; COME HOME = Community Oncology Medical Home; IPU = Integrated Practice Unit.
Abstract Only
Graduate School Dissertation